An updated review of genetic associations with severe adverse drug reactions: Translation and implementation of pharmacogenomic testing in clinical practice

CW Wang, IAC Preclaro, WH Lin… - Frontiers in …, 2022 - frontiersin.org
Adverse drug reactions (ADR) remain the major problems in healthcare. Most severe ADR
are unpredictable, dose-independent and termed as type B idiosyncratic reactions. Recent …

Translational pharmacogenomics: discovery, evidence synthesis and delivery of race‐conscious medicine

BH Davis, NA Limdi - Clinical Pharmacology & Therapeutics, 2021 - Wiley Online Library
Response to medications, the principal treatment modality for acute and chronic diseases, is
highly variable, with 40–70% of patients exhibiting lack of efficacy or adverse drug reactions …

Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians

CW Wang, W Tassaneeyakul, CB Chen… - Journal of Allergy and …, 2021 - Elsevier
Background Co-trimoxazole, a sulfonamide antibiotic, is used to treat a variety of infections
worldwide, and it remains a common first-line medicine for prophylaxis against …

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions

P Wattanachai, W Amornpinyo, P Konyoung… - Frontiers in …, 2023 - frontiersin.org
Introduction: Beta-lactam antibiotics are one of the most common causes of antibiotics-
related severe cutaneous adverse reactions (SCARs) including Stevens–Johnson syndrome …

Severe cutaneous adverse reactions

SI Hung, M Mockenhaupt, KG Blumenthal… - Nature Reviews …, 2024 - nature.com
Severe cutaneous adverse reactions (SCARs), which include Stevens–Johnson syndrome
and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (also …

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antibiotic use: a case-crossover study

T Fukasawa, H Urushihara, H Takahashi… - The Journal of Allergy …, 2023 - Elsevier
Background Evidence is lacking on the association between antibiotic use and risk of
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Asians. Objective …

Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies

CC Lin, CB Chen, CW Wang, SI Hung… - Expert Review of …, 2020 - Taylor & Francis
Introduction: The clinical manifestations of cutaneous adverse drug reactions are variable
with different severity. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis …

A nationwide study of severe cutaneous adverse reactions based on the multicenter registry in Korea

DY Kang, J Yun, SY Lee, YI Koh, S Kim, YH Nam… - The Journal of Allergy …, 2021 - Elsevier
Background Because severe cutaneous adverse reactions (SCARs), such as Stevens-
Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with …

Stevens-Johnson syndrome following non-steroidal anti-inflammatory drugs: a real-world analysis of post-marketing surveillance data

Q Shao, X Yin, N Zeng, Z Zhou, X Mao, Y Zhu… - Frontiers in …, 2022 - frontiersin.org
Background: The Stevens-Johnson syndrome (SJS) is a severe skin reaction to non-
steroidal anti-inflammatory drugs (NSAIDs), and can even be life-threatening. However …

Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade

CB Chen, SI Hung, JWC Chang, CK Yang… - Nature …, 2024 - nature.com
Immune checkpoint inhibitors (ICI) represent new anticancer agents and have been used
worldwide. However, ICI can potentially induce life-threatening severe cutaneous adverse …